Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 28, 2018

View Archived Issues

Aldeyra Therapeutics, Janssen enter systemic inflammatory disease collaboration

BMS licenses Domain Therapeutics' bioSens-All technology

IL17F His161Arg gene polymorphism found positively associated with psoriasis

EMA grants orphan drug designation to cannabidiol for tuberous sclerosis

Beacon Discovery enters GPCR drug discovery collaboration with Takeda

Intensity Therapeutics reports data from phase I/II study of INT-230-6

EMA gives accelerated assessment to Shire's lanadelumab

Mannose-binding lectin tied to influenza-associated critical illness in children

Cereblon gene knockout mimics autosomal recessive non-syndromic intellectual disability

PhaseBio Pharmaceuticals receives NIH grant to support PB-1046 development

Dyadic enters funded proof-of-concept research collaboration with Mitsubishi Tanabe

Novo Nordisk submits regulatory applications for N8-GP in U.S. and E.U.

Dendritic cell-based DNA vaccine effectively protects against herpes simplex virus keratitis in vivo

FDA accepts Tetraphase's NDA for eravacycline

Orphelia Pharma announces MAA filing for Kigabeq

Ophthotech, University of Massachusetts collaborate on novel gene therapies for ophthalmic diseases

Shanghai De Novo Pharmatech divulges new IDO1 inhibitors

Cynata reports updated data from phase I trial of CYP-001 in steroid-resistant GvHD

European Commission approves Hemlibra

Zafgen presents novel MetAP 2 inhibitors

RWTH Aachen discloses novel ATR kinase inhibitors

FDA accepts Shire's BLA for calaspargase pegol

Quentis Therapeutics completes series A financing to advance first-in-class immunotherapies

SK Chemicals and Sanofi patent vaccine compositions for streptococcal infection

Reata updates timeline for bardoxolone methyl studies in rare forms of chronic kidney disease

Senti Biosciences closes series A financing to develop gene and cell-based therapies

Novel anti-PD-1 antibodies presented by Y-Biologics

Abbott and Surmodics enter agreement for SurVeil drug-coated balloon

Phase III study of Hisamitsu's HP-3000 transdermal patch meets primary endpoint

Celgene receives FDA refusal to file letter for ozanimod NDA in relapsing MS

TRPM4 gene polymorphisms associated with cerebral edema in TBI patients

Reminder -- we want your opinion on TRDN

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 4, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...